
Sihong Huang
Examiner (ID: 14444)
| Most Active Art Unit | 2736 |
| Art Unit(s) | 2632, 2617, 2736 |
| Total Applications | 250 |
| Issued Applications | 200 |
| Pending Applications | 18 |
| Abandoned Applications | 32 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18223618
[patent_doc_number] => 20230062612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => SAFETY SWITCHES FOR REGULATION OF GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/793008
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -266
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793008 | SAFETY SWITCHES FOR REGULATION OF GENE EXPRESSION | Jan 14, 2021 | Pending |
Array
(
[id] => 18210582
[patent_doc_number] => 20230056844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => CELL CULTURE SUBSTRATE AND MANUFACTURING METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/788886
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788886 | Cell culture substrate and manufacturing method therefor | Dec 27, 2020 | Issued |
Array
(
[id] => 18144521
[patent_doc_number] => 20230018373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => AUTOMATED PRODUCTION OF VIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/757345
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757345 | AUTOMATED PRODUCTION OF VIRAL VECTORS | Dec 17, 2020 | Pending |
Array
(
[id] => 19050889
[patent_doc_number] => 20240092858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => TREATMENT OF CONGENITAL STATIONARY NIGHT BLINDNESS USING GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/255951
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255951
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255951 | TREATMENT OF CONGENITAL STATIONARY NIGHT BLINDNESS USING GENE THERAPY | Dec 7, 2020 | Pending |
Array
(
[id] => 18034657
[patent_doc_number] => 20220378872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => COMPOSITION FOR TREATMENT AND/OR PREVENTION OF TUMOR
[patent_app_type] => utility
[patent_app_number] => 17/755294
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755294 | COMPOSITION FOR TREATMENT AND/OR PREVENTION OF TUMOR | Oct 29, 2020 | Abandoned |
Array
(
[id] => 18816123
[patent_doc_number] => 20230390463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => TISSUE SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 18/250873
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250873
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250873 | TISSUE SCAFFOLDS | Oct 26, 2020 | Pending |
Array
(
[id] => 18093427
[patent_doc_number] => 20220411768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHODS OF PERFORMING RNA TEMPLATED GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 17/770917
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770917 | METHODS OF PERFORMING RNA TEMPLATED GENOME EDITING | Oct 18, 2020 | Abandoned |
Array
(
[id] => 18158697
[patent_doc_number] => 20230025289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => CD24 EXPRESSING CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/637789
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637789 | CD24 EXPRESSING CELLS AND USES THEREOF | Aug 23, 2020 | Pending |
Array
(
[id] => 17852177
[patent_doc_number] => 20220282219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => GENETICALLY ENGINEERED HUMAN FETAL LIVER NICHE AS PLATFORM FOR BIOMANUFACTURING OF HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/634766
[patent_app_country] => US
[patent_app_date] => 2020-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634766 | GENETICALLY ENGINEERED HUMAN FETAL LIVER NICHE AS PLATFORM FOR BIOMANUFACTURING OF HEMATOPOIETIC STEM CELLS | Aug 11, 2020 | Pending |
Array
(
[id] => 17988933
[patent_doc_number] => 20220354970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => TRANSGENIC NON-HUMAN ANIMAL CAPABLE OF CONTROLLING EXPRESSION OF TRANSCRIPTION FACTOR RP58
[patent_app_type] => utility
[patent_app_number] => 17/628793
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628793 | TRANSGENIC NON-HUMAN ANIMAL CAPABLE OF CONTROLLING EXPRESSION OF TRANSCRIPTION FACTOR RP58 | Jul 21, 2020 | Abandoned |
Array
(
[id] => 20700289
[patent_doc_number] => 12622980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Nucleic acid loaded flowable hydrogels and compositions, systems and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 17/627440
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 15277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627440 | Nucleic acid loaded flowable hydrogels and compositions, systems and methods related thereto | Jul 14, 2020 | Issued |
Array
(
[id] => 17805821
[patent_doc_number] => 20220257656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 17/625442
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625442 | SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS | Jul 8, 2020 | Pending |
Array
(
[id] => 17792398
[patent_doc_number] => 20220251489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => CELL CULTURE SCAFFOLD, PRODUCTION METHOD THEREOF, SCAFFOLD PRODUCTION KIT, AND PRODUCTION METHOD OF CELL CULTURE PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/623738
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623738 | CELL CULTURE SCAFFOLD, PRODUCTION METHOD THEREOF, SCAFFOLD PRODUCTION KIT, AND PRODUCTION METHOD OF CELL CULTURE PRODUCT | Jul 5, 2020 | Pending |
Array
(
[id] => 18005347
[patent_doc_number] => 20220364113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => HOST SYSTEMS COMPRISING INHIBITORS OF A GENE-EDITING PROTEIN FOR PRODUCTION OF VIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/623412
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623412 | HOST SYSTEMS COMPRISING INHIBITORS OF A GENE-EDITING PROTEIN FOR PRODUCTION OF VIRAL VECTORS | Jul 1, 2020 | Abandoned |
Array
(
[id] => 18064496
[patent_doc_number] => 20220395583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => COMPOSITIONS AND METHODS FOR GENE REPLACEMENT
[patent_app_type] => utility
[patent_app_number] => 17/624145
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624145 | COMPOSITIONS AND METHODS FOR GENE REPLACEMENT | Jul 1, 2020 | Pending |
Array
(
[id] => 20402442
[patent_doc_number] => 12492412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Vector compositions and methods of using same for treatment of lysosomal storage disorders
[patent_app_type] => utility
[patent_app_number] => 17/624196
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 30
[patent_no_of_words] => 23693
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624196 | Vector compositions and methods of using same for treatment of lysosomal storage disorders | Jul 1, 2020 | Issued |
Array
(
[id] => 18227654
[patent_doc_number] => 20230066648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHOD FOR INDUCING TRANSDIFFERENTIATION OF SOMATIC CELLS INTO MAMMARY EPITHELIAL CELLS IN VITRO USING SMALL MOLECULE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/795607
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795607 | METHOD FOR INDUCING TRANSDIFFERENTIATION OF SOMATIC CELLS INTO MAMMARY EPITHELIAL CELLS IN VITRO USING SMALL MOLECULE COMPOUND | Jun 29, 2020 | Abandoned |
Array
(
[id] => 17881233
[patent_doc_number] => 20220296710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => MODULAR PHAGE VECTOR PLATFORM FOR SONODYNAMIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/596746
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596746
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596746 | Modular phage vector platform for sonodynamic therapy | Jun 25, 2020 | Issued |
Array
(
[id] => 17897331
[patent_doc_number] => 20220306993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => ERYTHROCYTE REMOVAL DEVICE, MONONUCLEAR CELL COLLECTOR, CELL CULTURE DEVICE, CELL CULTURE SYSTEM, CELL CULTURE METHOD, AND MONONUCLEAR CELL COLLECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/617876
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617876 | Erythrocyte removal device, mononuclear cell collector, cell culture device, cell culture system, cell culture method, and mononuclear cell collection method | Jun 9, 2020 | Issued |
Array
(
[id] => 17759847
[patent_doc_number] => 20220233459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => ANALYSIS OF MATERIALS FOR TISSUE DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/596187
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596187 | ANALYSIS OF MATERIALS FOR TISSUE DELIVERY | Jun 1, 2020 | Abandoned |